SCHEMBL14743303

SCHEMBL14743303

Clc1ccc([SiH](c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.53
CYP1A2 P05177 1/20 0.50
LMNA P02545 3/20 0.44
CYP2A6 P11509 2/20 0.44
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
ORAI1 Q96D31 1/20 0.41
ORAI2 Q96SN7 1/20 0.41
ORAI3 Q9BRQ5 1/20 0.41
TRPV6 Q9H1D0 1/20 0.41
ALOX15 P16050 1/20 0.40
IDO1 P14902 3/20 0.37
TDO2 P48775 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
KDM4E B2RXH2 1/20 0.37
GAA P10253 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
SRD5A2 P31213 1/20 0.36
NOX1 Q9Y5S8 1/20 0.34
G6PD P11413 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8459846 0.88 LMNA (0.57) TSHRCYP1A2LMNACYP2A6CES2
SCHEMBL703965 0.85 ALDH1A1 (0.38) TSHRLMNACYP2A6ALOX15L3MBTL1
SCHEMBL38902 0.82 ALDH1A1 (0.40) TSHRLMNACYP2A6CES2CES1
SCHEMBL38651919 0.78 ALDH1A1 (0.38) TSHRLMNACYP2A6ALOX15L3MBTL1
SCHEMBL10422510 0.78 ALDH1A1 (0.38) TSHRLMNACYP2A6ALOX15L3MBTL1
Ammonia Solution, Strong SCHEMBL3895204 0.78 ALDH1A1 (0.38) TSHRLMNACYP2A6ALOX15L3MBTL1
SCHEMBL11256956 0.78 ALDH1A1 (0.38) TSHRLMNACYP2A6ALOX15L3MBTL1
SCHEMBL11588969 0.78 ALDH1A1 (0.38) TSHRLMNACYP2A6ALOX15L3MBTL1
Hydrochloric Acid SCHEMBL1400215 0.78 ALDH1A1 (0.38) TSHRLMNACYP2A6ALOX15L3MBTL1
SCHEMBL11589221 0.78 ALDH1A1 (0.38) TSHRLMNACYP2A6ALOX15L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114621279-A Preparation method for aryl silane dimer compound through aryl silane self-coupling synthesis under photocatalysis 湖南农业大学 2022-06-14 CN disclosed
CN-108727424-B Organic compound, application thereof and organic electroluminescent device 北京绿人科技有限责任公司 2020-10-02 CN disclosed
CN-110088112-A Compound for electronic device 默克专利有限公司 2019-08-02 CN disclosed
US-9233922-B2 Process for producing N-(hetero)arylazoles TAKASAGO INTERNATIONAL CORPORATION (JP) 2016-01-12 US disclosed
EP-2736881-B1 PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES TAKASAGO PERFUMERY CO LTD (JP) 2015-10-07 EP disclosed
US-20140371461-A1 PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES TAKASAGO INTERNATIONAL CORPORATION (JP) 2014-12-18 US disclosed
EP-2736881-A1 PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES Takasago International Corporation (JP) 2014-06-04 EP disclosed
WO-2013032035-A1 PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES TAKASAGO INTERNATIONAL CORPORATION (JP) 2013-03-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140371461-A1 PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES CYP3A4, HCN4, PPOX TSHR 3816/4885CYP1A2 64/4885LMNA 3840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.